1. Role of Verotoxin producing Escherichia cofi tivity which may help indicate the primary I Ellis 10, Hitchcock A. Tumour marker in the aetiology of haemorrhagic colitis site. This is clearly an important study as it immunoreactivity in adenocarcinoma,J
2. Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable condition;Ann Intern Med,1986
3. Curative combination chemotherapy for patients with advanced poorly differentiated carcinoma of unknown primary site;Hainsworth, J.D.; Dial, T.W.; Greco, F.A.;Am; Clin Oncol incidence of Verotoxin producing Escherichia coli (VTEC) in haemorrhagic colitis was conducted from I January 1986 to 31 December 1987.2 During this time we searched for VTEC in faecal samples from 40 patients with haemorrhagic colitis (sudden onset of grossly bloody diarrhoea,1988
4. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognised clinicopathological entity;Hainsworth, J.D.; Johnson, D.H.; Greco, F.A.;Ann Intern Med,1988